Your browser doesn't support javascript.
loading
Medicare Opt-Out Trends Among Dermatologists May Reflect Systemic Health Policy: Cross-sectional Analysis.
Agarwal, Aneesh; Han, Joseph; Luu, Yen; Gulati, Nicholas.
Afiliação
  • Agarwal A; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Han J; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Luu Y; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
  • Gulati N; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
JMIR Dermatol ; 5(4): e42345, 2022 Nov 08.
Article em En | MEDLINE | ID: mdl-37632903
ABSTRACT

BACKGROUND:

Provider opt-out of accepting Medicare insurance is a nationally tracked metric by the Centers for Medicare & Medicaid Services (CMS) for all physicians, including dermatologists. Although this usually only consists of a small number of providers, the magnitude of opting out has varied historically, often tracing changes in systemic health care policy.

OBJECTIVE:

In this paper, we explored dermatologist opt-out data since 2001, as reported by the CMS, to characterize trends and provide evidence that shifts in provider opt-out may represent a potential indicator of the state of health policy and possible needs for reform as it pertains to Medicare.

METHODS:

The publicly available Opt Out Affidavits data set, available from the CMS, was evaluated for providers in all dermatologic specialties from January 1, 2001, to May 27, 2022.

RESULTS:

There were a total of 196 dermatology opt-outs in the overall period, with the largest spike being 33 providers in 2016, followed by generally consistent decreases through 2021. In the most recent 12 months of data, the number of new monthly opt-outs from January 2022 to May 2022 was significantly higher than that of the trailing 7 months of 2021 (P=.03).

CONCLUSIONS:

Despite decreasing numbers of dermatologist opt-outs in the late-2010s, 2022 was marked by a significant increase in opt-outs. The reduced acceptance of Medicare by dermatologists may present risks to care access, so it is important to frequently assess physician opt-out data and changes over time.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: JMIR Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: JMIR Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos